期刊文献+

MMC与DDP交替腔内化疗治疗肺癌并心包积液

Alternative Intra-pericardial Chemotherapy of MMC and DDP in the Treatment of Patients with Lung Cancer and Pericardial Effusion
下载PDF
导出
摘要 目的:观察总结丝裂霉素(MMC)与顺铂(DDP)交替化疗治疗肺癌并心包积液的疗效及毒性反应。方法:37例肺癌并心包积液患者均在B超或彩超引导下心包腔置入中心静脉导管引流,每日少量引流并MMC与DDP交替腔内化疗(其中MMC 2mg/d、DDP 20~30 mg/d至MMC总量8~10 mg、DDP 90~100 mg)。结果:CR 25例,PR 10例,NR 2例,总有效率94.6%。治疗后发热4例,其中高热1例;胃肠道反应12例,主要为Ⅰ~Ⅱ度;骨髓抑制14例,主要为Ⅰ度。结论:心包腔闭式引流加MMC与DDP小剂量交替化疗是控制肺癌并心包积液的有效方法。 Objective: To observe and summarize the efficacy and side effect ofintra-pericardial chemotherapy of MMC and DDP on malignant pericardial effusion of lung cancer. Methods: Thirty-seven cases of lung cancer with malignant pericardial effusion were all drained with using central venous catheter guided by B-mode or color Doppler ultrasound. A small amount of drainage was conducted on daily basis with alternative intra-pericardial chemotherapy of MMC and DDP (there into, MMC 2 mg/d, DDP 20-30 mg/d to the total of MMC to 8-10 mg, DDP 90-100 mg). Result: The total effective rate was 94.6% with 25 cases of CR and 10 cases of PR. After treatment, 4 patients developed fever (1 case of high fever), 19 eases developed gastrointestinal tract reaction (mainly grade Ⅰ - Ⅱ), 14 developed myelosuppression (mainly grade Ⅰ ). Conclusion: Central venous catheter drainage with alternative injection of MMC and DDP in small doses into pericardial cavity may be a better way to control malignant pericardial effusion of lung cancer.
作者 邱慧萍
出处 《实用中西医结合临床》 2015年第5期13-14,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
关键词 肺癌并心包积液 腔内化疗 MMC(丝裂霉素) DDP(顺铂) Lung cancer, Pericardial effusion Intra-pericardial chemotherapy MMC (Mitomycin) DDP (Cisplatin)
  • 相关文献

参考文献4

二级参考文献11

  • 1宋恕乎,杨锡贵,陈阵.临床肿瘤转移学[M].济南:山东科学技术出版社,2001:99-119.
  • 2王金万,孙燕.白介素-2[M]//周际昌.实用肿瘤内科学.北京:人民卫生出版社,2003:413-415.
  • 3Martinoni A,Cipolla C M,Civelli M,et al.Intrapericardial treatment of neoplastic pericardial effusions[J].Herz,2000,25(8):787-793.
  • 4Maher E A,Shepherd F A,Todd T J.Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade[J].J Thorac Cardiovasc Surg,1996,112(3):637-643.
  • 5DeCamp M M Jr,Mentzer S J,Swanson S J,et al.Malignant effusive disease of the pleura and pericardium[J].Chest,1997,112(4):291S-295S.
  • 6Kaira K,Takise A,Kobayashi G,et al.Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer[J].Jpn J Clin Oncol,2005,35(2):57-60.
  • 7Martinoni A,Cipolla C M,Cardinale D,et al.Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa[J].Chest,2004,126(5):1412-1416.
  • 8Tomkowski W Z,Filipecki S.Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer[J].Lung Cancer,1997,16(2-3):215-222.
  • 9寇卫政,牛红蕊,王颖,路平,苗战会.导管持续引流并注射博来霉素治疗恶性心包积液[J].中国民康医学,2009,21(2):99-100. 被引量:3
  • 10章华萍,徐颖鹤,林荣海.心包引流及腔内注射化疗药物治疗伴填塞症状的恶性心包积液17例分析[J].临床荟萃,2001,16(21). 被引量:6

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部